Transcriptomic Signatures of Auger Electron Radioimmunotherapy Using Nuclear Targeting111In-Trastuzumab for Potential Combination Therapies

Cancer Biotherapy and Radiopharmaceuticals - United States
doi 10.1089/cbr.2015.1882
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Trastuzumab-Resistant Breast Cancer Cells Remain Sensitive to the Auger Electron-Emitting Radiotherapeutic Agent 111In-NLS-Trastuzumab and Are Radiosensitized by Methotrexate

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2008English

Measurement of Secondary Electron Yield of Wall Materials Using Auger Electron Spectrometer.

SHINKU
1987English

Transcriptomic Signatures for Tertiary Pattern 5 in Prostate Cancer

BJU International
Urology
2019English

Transcriptomic Signatures Decode Th17 Cell Pathogenicity

Cellular and Molecular Immunology
Infectious DiseasesMedicineAllergyImmunology
2016English

Recent Applications of Auger Electron Spectroscopy

Hyomen Kagaku
2016English

The Potential of Radioimmunotherapy as a New Hope for HIV Patients

Expert Review of Clinical Immunology
AllergyImmunology
2014English

Auger Electron Spectroscopy Using 2-Grid LEED System and Photoelectron Multiplier

SHINKU
1972English

Auger Electron Spectroscopy of Insulator Polyimide Films.

SHINKU
1985English

Blood Signatures for Second Stage Human African Trypanosomiasis: A Transcriptomic Approach

BMC Medical Genomics
Genetics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy